bioRxiv Science⌕ Search

bioRxiv · 10.1101/674184

Effect of calcium intake and dietary cation anion difference in early lactation on bone mobilization dynamics all over lactation in dairy cows

Abstract

This study aimed to evaluate the consequences of increased bone mobilization in early lactation on the dynamics of the milk Ca content during lactation and bone reconstitution. Fifteen multiparous Holstein cows were distributed among 3 treatments 5 weeks before their expected calving date. Those treatments consisted of the provision of dedicated diets through the first 10 weeks of lactation. During that period, the control treatment (NCa) consisted of a diet providing 100\\% of the Ca requirements, with a dietary cation-anion difference (DCAD) of 200 mEq/kg DM. The treatments LCa (Low Ca) and LCaLD (Low Ca, Low DCAD) consisted of diets providing 70% of the Ca requirements, with a DCAD of 200 and 0 mEq/kg DM for LCa and LCaLD, respectively. After 10 weeks, all cows received the same total mixed ration which was formulated to meet 100\\% of the Ca requirements. LCa and LCaLD tended to decrease the body retention of Ca at 3 weeks of lactation compared with NCa, but did not affect either the dynamics of the blood biomarkers of bone formation and resorption during the lactation or the body retention of Ca at 17 weeks of lactation. Cows almost entirely compensated for the decrease in Ca supply by increasing their apparent digestive absorption of Ca at 3 weeks of lactation, whereas the apparent digestive absorption was unaffected by the treatments at 17 weeks of lactation. Milk production tended to be lower throughout lactation with the LCa and LCaLD compared with the NCa, with a mean difference of 2 kg/d. This study indicated that measuring the dynamics of the milk Ca content during lactation cannot be considered effective for indirectly estimating the dynamics of bone mobilization of cows. The results also showed that limited Ca intake at the beginning of lactation can have deleterious effect on milk production.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gaignon, P., Le Grand, K., Laza-Knoer, A.-L., Hurtaud, C., Boudon, A.. 2019-06-17. Effect of calcium intake and dietary cation anion difference in early lactation on bone mobilization dynamics all over lactation in dairy cows. https://doi.org/10.1101/674184

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

28S-rsRNA facilitates PASMC proliferation through PKM2 β-hydroxybutyrylation

Ribosomal RNA-derived small RNAs (rsRNAs) are nucleic acid fragments originating from rRNA, the functions and roles of which in diseases remain incompletely understood. We identified 28S rsRNA-CTC_L20, an rsRNA whose expression is upregulated in hypoxic pulmonary artery smooth muscle cells (PASMCs) and in lung tissues of pulmonary hypertension (PH) models. In hypoxic cells, 28S rsRNA-CTC_L20 promotes PASMC proliferation, and its knockdown mitigates SuHx-induced pulmonary hypertension and vascular remodeling. Mechanistically, 28S rsRNA-CTC_L20 modulates {beta}-hydroxybutyrate (BHB) production by maintaining the stability of ketogenic enzyme mRNAs through its "CTGNNGG" motif. Elevated levels of BHB enhance the {beta}-hydroxybutyrylation modification at K166 of pyruvate kinase M2 (PKM2), increasing its activity and driving glycolysis to sustain proliferation. These results link ketone body metabolism to glycolysis in hypoxic cells and define an rsRNA-BHB-PKM2 {beta}-hydroxybutyrylation axis in PH. They also point to 28S rsRNA-CTC_L20 as a potential target for treating vascular remodeling.

physiology↗

Selective activation of estrogen receptors modulates electrical activity and insulin secretion in human EndoC-βH1 cells

Estrogen receptors (ERs), ER and ER{beta} have important roles in the physiology of the endocrine pancreas in animal models, but the effects of ER activation on insulin-secreting human cells are still poorly understood. Here, we investigated the role of ER and ER{beta} as modulators of electrical activity and insulin secretion in the insulin-secreting human cell line EndoC-{beta}H1. Immunocytochemical analysis revealed a widespread cellular distribution of ER, while ER{beta} was predominantly localized outside the nucleus. We observed that both estradiol (E2) and the ER{beta} agonist diarylpropionitrile (DPN) led to a decrease in insulin secretion in the absence of stimulatory glucose concentrations, without affecting insulin content. Patch-clamp experiments revealed that a 48-hour treatment with either the ER agonist PPT or DPN resulted in depolarization of the resting membrane potential, increased action potential firing frequency, and altered the action potential waveform in EndoC-{beta}H1 cells. PPT increased voltage-dependent Ca2+ channel currents, while DPN reduced K+ and Na+ currents. These results suggest that activation of ER and ER{beta} modulates beta-cell electrical activity through distinct pathways involving ion channels. The effects of E2, PPT, and DPN were not caused by altered expression levels of ion channel genes after 48 hours of treatment. This suggests that these receptors act extranuclearly without affecting gene expression. Together, our findings demonstrate that selective activation of ER and ER{beta} modulates beta-cell excitability through distinct electrophysiological mechanisms and that E2 and DPN reduce basal insulin secretion in human EndoC-{beta}H1 cells. These results support ER and ER{beta} as potential targets for modulating human pancreatic beta-cell function.

physiology↗

Body weight modifies the efficacy of lifespan-extending interventions in ad libitum-fed mice

Geroprotective interventions are often assessed by extension of lifespan in ad libitum-fed mice. Increased lifespan could therefore reflect rescue of adverse phenotypes of unhealthy controls. We analysed body weight and survival for 33,780 mice in the Interventions Testing Program (ITP) to test whether treatment effects varied with body weight. In males, each added standard deviation of attained adult weight made treatment 6% more favourable (HR 0.94), more apparent for interventions that lowered body weight (HR 0.90). Median lifespan increase rose from 6.2% in mice in the lightest quartile to 20.2% in the heaviest pre-dosing weight quartile among those experiments, mainly because control survival declined more steeply with weight than that of the intervention group. The effect of body weight was consistent across 13 of 14 compounds and reflected weight attained during adulthood rather than in early life. Weight-dependence of intervention effects was weak in ITP females, possibly because median survival of controls exceeded that of every sampled non-ITP female control group. Amelioration of weight-associated risk is therefore implicated as a major contributor to lifespan increases relative to heavy, short-lived controls. The geroprotective effects of these interventions may thus be less apparent in metabolically healthier mice or humans.

physiology↗